U.S. Preeclampsia Laboratory Testing Market Value Worth US$3,040.5 Mn by 2026, at a decent CAGR of 5.1% - PowerPoint PPT Presentation

About This Presentation
Title:

U.S. Preeclampsia Laboratory Testing Market Value Worth US$3,040.5 Mn by 2026, at a decent CAGR of 5.1%

Description:

The scope of reproductive care now widely encompasses preeclampsia screening. This is projected to drive the U.S. preeclampsia laboratory testing market. Undiagnosed and untreated preeclampsia has been a major cause for foetal and maternal mortality. This can be prevented through efficient preeclampsia diagnosis. Additionally, the number of COVID-19 positive pregnant women is on the rise which is increasing their chances of developing this fatal condition. – PowerPoint PPT presentation

Number of Views:14

less

Transcript and Presenter's Notes

Title: U.S. Preeclampsia Laboratory Testing Market Value Worth US$3,040.5 Mn by 2026, at a decent CAGR of 5.1%


1
Higher Incidence of Severe Preeclampsia Drives
Growth of U.S. Preeclampsia Laboratory Testing
Market The scope of reproductive care now widely
encompasses preeclampsia screening. This is
projected to drive the U.S. preeclampsia
laboratory testing market. Undiagnosed and
untreated preeclampsia has been a major cause for
foetal and maternal mortality. This can be
prevented through efficient preeclampsia
diagnosis. Additionally, the number of COVID- 19
positive pregnant women is on the rise which is
increasing their chances of developing this
fatal condition. Check Complete Report Details of
market _at_ https//www.fairfieldmarketresearch.com/
report/us-preeclampsia-laboratory-testing-
market The U.S. preeclampsia laboratory testing
market will rise at a heathy CAGR of 5.1 during
the forecast period of 2021-2026, reaching the
market volume of 4,629,000 by 2026. As countries
undergo an escalated rate of health-related
risks, preeclampsia is reported as the third
leading cause of maternal mortality in the U.S
alone. According to Fairfield Market Research,
the U.S. preeclampsia laboratory testing market
will be worth US3,040.5 Mn by 2026. Higher
Caseload of Preeclampsia-Related Births Fuels
U.S. Market The U.S. preeclampsia laboratory
testing market primarily benefits from high
prevalence of severe preeclampsia coupled with
several product launches to cater to this surging
caseload. Cases of severe preeclampsia have been
mushrooming in recent times, generating palpable
alarm across the healthcare sector. The Centres
for Disease Control and Prevention states that
preeclampsia is seen in every 1 in 25 pregnancies
in the U.S. Furthermore, its also the cause of
15 premature births in the country. Blood Tests
to Hold Significant Share in U.S. Preeclampsia
Laboratory Testing Market Blood tests hold a
sizeable lead in the test type category of the
preeclampsia laboratory testing market and this
propensity is not projected to undergo major
deviances in the times to follow. Patients opt
for blood tests over other options because of
their higher accuracy rates. The report states
that the blood test segment is expected to
register a CAGR of 7.6 between the forecast
period of 2021 and 2026. Proactive Healthcare
Workforce and Robust Infrastructure Favours
Growth of U.S. Preeclampsia Laboratory Testing
Market The healthcare industry in the U.S. has
played a preeminent role in improving
preeclampsia laboratory testing across the
region. The presence of numerous patient advocacy
groups as
2
  • well as government initiatives to develop better
    diagnostics regimen in the U.S. are strong
    contributors to the regional markets dominance.
    The US Preventive Services Task Force has been
    making dedicated efforts to ensure proper
    management of screening tests. This is a
    critical success factor for the growth of the
    regional market. The regional market is also
    expected to witness rife growth opportunities,
    attracting interest of healthcare and
    pharmaceutical companies active in preeclampsia
    laboratory testing segment.
  • Table of Content
  • Executive Summary
  • U.S. Preeclampsia Laboratory Testing Market
    Outlook, 2018 - 2026 (US Million) and Volume
    (,000)
  • U.S. Preeclampsia Laboratory Testing Market
    Snapshot
  • U.S. Preeclampsia Laboratory Testing Market
    Incremental Opportunity, 2018 - 2026 (US
    Million) and Volume (,000)
  • Key Industry Trends
  • Market Overview
  • Market Definitions and Segmentations
  • Market Dynamics
  • Market Landscape
  • Preeclampsia Diagnostics Overview
  • MicroRNAs Promising Biomarker in Preeclampsia
  • Medical Management of Preeclampsia An Overview
  • Womens Attitudes, Beliefs and Values About
    Tests, And Management for Hypertensive Disorders
    Of Pregnancy
  • TOC Continued...!!!

3
Fairfield Market Research is a UK-based market
research provider. Fairfield offers a wide
spectrum of services, ranging from customized
reports to consulting solutions. With a strong
European footprint, Fairfield operates globally
and helps businesses navigate through business
cycles, with quick responses and multi-pronged
approaches. The company values an eye for
insightful take on global matters, ably backed by
a team of exceptionally experienced researchers.
With a strong repository of syndicated market
research reports that are continuously published
updated to ensure the ever-changing needs of
customers are met with absolute
promptness. Contact Fairfield Market
Research London, UK UK 44 (0)20 30025888 USA 1
(844) 3829746 (Toll-free) Web https//www.fairfie
ldmarketresearch.com/ Email sales_at_fairfieldmarke
tresearch.com Follow Us LinkedIn
Write a Comment
User Comments (0)
About PowerShow.com